Financials data is unavailable for this security.
View more
Year on year JZJ Chain Drugstore Corp grew revenues 20.84% from 7.51bn to 9.08bn while net income improved 10.72% from 374.29m to 414.41m.
| Gross margin | 35.54% |
|---|---|
| Net profit margin | 2.53% |
| Operating margin | 3.22% |
| Return on assets | 2.34% |
|---|---|
| Return on equity | 8.61% |
| Return on investment | 4.50% |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at JZJ Chain Drugstore Corp fell by 161.22m. However, the company earned 1.02bn from its operations for a Cash Flow Margin of 11.28%. In addition the company used 522.54m on investing activities and also paid 663.09m in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 17.72 |
|---|---|
| Tangible book value per share | 1.40 |
More ▼
Balance sheet in CNYView more
| Current ratio | 0.8433 |
|---|---|
| Quick ratio | 0.2655 |
| Total debt/total equity | 1.90 |
|---|---|
| Total debt/total capital | 0.6563 |
More ▼
Growth rates in CNY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 14.42% and 8.78%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 69.92% |
| EPS growth(5 years) | 16.05 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -39.81 |
More ▼
